Niels Behrendt

6PUBLICATIONS
45CO-AUTHORS
Haematological tumoursColloid and surface chemistryBiomedical imagingMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 29, 2026
TCRVβ-targeting antibody-drug conjugates as a novel strategy to eliminate malignant T cells in T cell cancers.

|Jan 27, 2026
uPA-mediated remodeling of CCL21 gradients regulates lymphatic migration of dendritic cells.

Victor Collado-Diaz, Maria-Nefeli Christakopoulou, Philipp Schineis

|Dec 10, 2025
Targeting uPARAP with an Antibody-Drug Conjugate Exhibits Efficacy against Mesothelioma and Synergizes with Cisplatin.

Pınar Çakılkaya, Ida Marie Egeland Larsen, Qun Jiang

|Jul 16, 2025
The Recycling Collagen Receptor uPARAP Is a Unique Mediator of Stromal Drug Delivery to Carcinoma Cells.

Kirstine S Nørregaard, Ida M E Larsen, Henrik J Jürgensen

|Nov 13, 2021
The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target.

Pınar Çakılkaya, Rikke Raagaard Sørensen, Henrik Jessen Jürgensen

|Oct 28, 2018
Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins.

Henrik J Jürgensen, Kirstine S Nørregaard, Megan M Sibree

Pageof 1

Frequent Collaborators

3 joint publications

Alba Martinez Perlado

3 joint publications

Pınar Çakılkaya

3 joint publications

Henrik Jessen Jürgensen

3 joint publications

Oliver Krigslund